期刊文献+

盐酸法舒地尔联合丹红注射液治疗不稳定型心绞痛疗效的观察 被引量:1

The therapectic effect of fasudil hydrochloride and Danhong injection on the unstable angina
下载PDF
导出
摘要 目的:观察应用盐酸法舒地尔联合丹红注射液治疗不稳定型心绞痛的疗效,为临床治疗提供依据。方法:将90例不稳定型心绞痛患者随机分为治疗组和对照组,每组各45例,治疗组在常规治疗方法基础上,加用盐酸法舒地尔与丹红注射液,对照组仅常规治疗,按照显效、好转、无效原则观察治疗效果并进行组间比较。结果:对照组显效17例,好转15例,无效13例,总有效率为71.11%。治疗组显效31例,好转11例,无效3例,总有效率为93.33%。治疗组总有率明显高于对照组(P<0.05)。结论:用盐酸法舒地尔联合丹红注射液治疗不稳定型心绞痛可提高临床疗效,改善生活质量。 Objective To observation of fasudil hydrochloride combined with Danhong injection in the treatment of unstable angina pectoris patients,to provide basis for clinical therapy.Methods 90 cases of unstable angina pectoris patients were randomly divided into treatment group and control group,45 cases in each group,the treatment group was treated with routine treatment method,combined with fasudil hydrochloride with Danhong injection,control group only conventional treatment,according to the results,better,invalid principles observed treatment effect and the groups comparison.Results in the control group 17 cases,15 cases were improved,13 cases ineffective,the total effective rate was 71.11%.The treatment group 31 cases,11 cases were improved,3 cases ineffective,the total effective rate was 93. 33%.The treatment group had total rate was higher than that of control group(P0.05).Conclusion fasudil hydrochloride combined with Danhong injection in the treatment of unstable angina pectoris may improve clinical outcomes,to improve the quality of life.
作者 蒋春如
出处 《求医问药(下半月刊)》 2012年第3期586-587,共2页 Seek Medical and Ask The Medicine
关键词 盐酸法舒地尔 丹红注射液 不稳定型心绞痛 疗效观察 Hydrochloric fasudil Danhong injection Unstable Angina Curative effect observation
  • 相关文献

参考文献8

二级参考文献28

  • 1李小鹰.阿司匹林在动脉硬化性心血管疾病中的临床应用:中国专家共识(2005)[J].中华心血管病杂志,2006,34(3):281-284. 被引量:194
  • 2中华人民共和国卫生部.中药新药临床研究指导原则[M].北京:中华人民共和国卫生部,1993.8-74. 被引量:222
  • 3Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines(Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol,2002, 40(7) :1366-1374. 被引量:1
  • 4Bertrand ME, Simoons ML, Fox KA, et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J,2002,23 ( 23 ) : 1809 -1840. 被引量:1
  • 5Erhardt L, Herlitz J, Bossaert L, et al. Task force on the management of chest pain. Eur Heart J, 2002, 23 ( 15 ) : 1153-1176. 被引量:1
  • 6CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet, 1996, 348(9038) :1329-1339. 被引量:1
  • 7Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med, 2001 , 345 ( 7 ) :494-502. 被引量:1
  • 8Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet, 2001, 358(9281):527-533. 被引量:1
  • 9Simoons ML, GUSTO IV-ACS Investigators. Effect of glycopmtein Ⅱb/Ⅲa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation:the GUSTO IV-ACS randomised trial. Lancet, 2001,357(9272) :1915-1924. 被引量:1
  • 10Platlat Receptor Inhibitor in Ischemic Syndrome Management(PRISM) study investigator. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. Platelet Receptor Inhibition in Ischemic Syndrome Management ( PRISM )Study Investigators. N Engl J Med, 1998, 338(21 ) :1498-1505. 被引量:1

共引文献2236

同被引文献5

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部